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Abstract
Background: Endometriosis is defined as the presence of endometrial glands and stroma at ectopic locations.
Although the prevalence of endometriosis is as high as 35 %–50 %, its pathogenesis remains controversial.
An increasing number of studies suggest that changes in immune reactivity may be primarily involved in the
development of endometriosis development. In this sense, it has been strongly suggested that a fundamental part of
immunologic system, the natural killer cells (NK cells), are an important part of this process. NK cells, a component of
the innate immune system, have been extensively studied for their ability to defend the organism against infections
and malignancy. Recent studies have shown that IL-2-activated NK (A-NK) cells are able to attack and destroy tumors in
lungs and livers of mice, demonstrating the therapeutic potential of these cells. Similarly to metastatic tumor cells,
endometrial cells are able to adhere, infiltrate and proliferate at ectopic locations. Therefore, in this study, we evaluated
the ability of adoptively transferred and endogenous NK cells to infiltrate endometriosis lesions.
Methods: As NK cells donors were used C57BL/6 B6. PL- Thy 1.1 female mice. As uterine horns donors were used C57/BL6
+GFP female mice and as endometriosis recipients C57BL/6 Thy1.2 female mice. Endometriosis induction was made by
injection of endometrial tissue fragments. After 4 weeks, necessary for endometriosis lesions establishment the animals were
divided in 3 experimental groups with 10 animals each. Group 1 received i.v doses of 5x106 A-NK in 200μl RPMI; Group 2
received i.p dose of 5x106 A-NK in 200μl RPMI and Group 3 received i.p dose of IL2 (0.5 mL RPMI containing 5.000U of IL2).
Results: Our data show that exogenous A-NK cells injected via ip combined with endogenous A-NK cells seems to be the
most efficient way for activated NK cells track and infiltrate endometriosis.
Conclusion: For the first time, it was shown that both endogenous as exogenous A-NK cells are able to track, migrate and
infiltrate endometriosis lesion. This seems to be a promising result, and if confirmed the efficiency of A-NK cells in killing
endometriosis lesions, maybe in the future we could use this approach as an alternative treatment for women with
endometriosis.
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Background
Endometriosis is cracterized by presence of endometrial
glands and stroma in ectopic locations, as pelvic periton-
eum, ovaries, and rectovaginal septum, affecting 6 % to
10 % of women in reproductive age [1]. Endometriosis
can cause dysmenorrhea, dyspareunia, chronic pelvic
pain and infertility [1]. The prevalence of endometriosis
in women experiencing pain, infertility, or both is as
high as 35 %–50 % [2]. The pathogenesis of endometri-
osis remains controversial. Currently, an increasing
number of studies have addressed whether changes in
immune reactivity may facilitate development of endo-
metriosis [3–5]. In this sense, it has been strongly sug-
gested that a fundamental part of immunologic system,
the natural killer cells (NK cells), are an important part
of this process [6, 7].
NK cells are large granular lymphocytes, representing
about 5 % to 15 % of peripheral blood lymphocytes [8].
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Fig. 1 Experimental endometriosis lesions 4 weeks after injection of endometrial tissue. Donor mice: GFP transgenic C57BL/6; Recipient mice:
wild-type (wt) C57BL/6. All pictures show endometriosis lesions from different animals
Fig. 2 GFP-positive endometriosis lesions. Experimental endometriosis lesions were induced by i.p injection of fragments of endometrium from GFP
transgenic C57BL/6 mice. The lesions were removed 4 weeks later, fixed in 4 % paraformaldehyde, frozen and sectioned. Sections were stained with
Hoechst 33342 to reveal cell nuclei. The endometriosis tissue is strongly positive for GFP, proving that the tissue is of donor origin. Image resolution-
20X. All micrographs show endometriosis lesions from different animals
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NK cells are an important component of the innate
immune system and have been extensively studied for
their ability to defend the organism against infections
and malignancies [9]. NK cells kill their targets by dir-
ect lysis or by the release of cytokines and chemokines
[10]. These reactions are carefully balanced and the
participation of cytokines such as interferons α and β
and interleukin 2 (IL-2) are essential [11]. In addition
to increasing the traffic of NK cells to sites of injury,
IL-2 activation has a strong proliferative effect on NK
cells [3]. Studies have shown that NK cells activated by
IL-2 (Adherent NK cells or A-NK cells) are able to
infiltrate and destroy tumors in lungs and livers of mice
[10, 11], suggesting that activated NK cells may be of
therapeutic importance in the setting of cancer. Recently,
a study demonstrated that activation of leucocytes with
IL-2, induced a persistent reduction of endometriosis
lesions in female rats [12]. On this basis, is possible that
IL-2 activated NK cells could form the basis of a new
treatment alternative for patients with endometriosis.
Results
Our analyses show that exogenous A-NK cells injected
via the i.v or i.p routes very efficiently infiltrate endo-
metriosis lesions (Figs. 3, 4). In non-treated animals,
endogenous NK cells are only found in very low
numbers in endometriosis lesions (Fig. 5). However, in
animals treated with A-NK cells plus IL-2 or with IL-2
alone, the density of endogenous NK cells in the endo-
metriotic lesions increased at least 10 fold (Figs. 6, 7).
Discussion
Endometriosis affects almost 10 % of women in the repro-
ductive age. The pathogenesis of endometriosis remains
controversial. However, many recent studies have impli-
cated the immune system and especially NK cells in
endometriosis development. On this basis, NK cells, a
fundamental part of immunologic system seems to play an
important role in endometriosis development. Several of
these studies have reported a decrease in cytotoxicity of
NK cells in the peritoneal fluid from women with endo-
metriosis [12, 13, 18]. Lack of NK cell cytotoxicity could, at
least in part, facilitate the attachment of endometriotic cells
at ectopic sites [6]. However, the reason for the decrease in
cytotoxicity of peritoneal fluid NK cells remains to be
clarified, but only few studies have assessed the role of NK
cells in target endometriosis lesions. Velasco and Cols
found that treatment of female rats with endometriosis
with IL-2 (two doses given by the i.p. route) resulted in the
activation of leucocytes and a significant reduction in the
size of endometriotic lesions compared to the untreated
group [12]. However, when they look for activated NK
Fig. 3 Exogenous A-NK cells injected intravenously localize at sites of endometriosis lesions. Fresh frozen endometriosis tissue was sectioned and
stained with PE anti-CD90.1 to reveal the Thy1.1+, adoptively transferred A-NK cells in the Thy1.2+ recipients. Sections were stained with Hoechst
33342 to reveal cell nuclei. Image resolution 20X. All micrographs (a-d) show endometriosis lesions from different animals
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cells, it seems to be in low number compared with control.
Differently, in our study we show that when activated by
IL2, endogenous NK cells starts to migrate to the lesion
becoming able to infiltrate it and that this effect seem to be
potentiate when exogenous A-NK were injected via i.v or
i.p. This important evidence shown at least in part that NK
cells seem really play an important role on pathogenesis of
endometriosis. We believe that ours findings were different
from those found for Velasco’s, first due the difference in
experimental model, and second due the difference in pro-
tocols accessed by each study. While we collected tissue
three days after A-NK cells induction, the other study wait
3 months to collect the simples, maybe this long time has
influenced in activity and quantity of NK cells. On the
other hand, due our short-term protocol, was not possible
observe changes in lesions size. Despite of this, for the first
time we show that activated NK cells are able to track and
infiltrate endometriosis lesions and the best way to pro-
mote this effect is through combination of endogenous
A-NK cells and exogenous A-NK cells injected via i.p.
Conclusions
Our results show at least in part that exogenous activated
NK cells enhance trafficking of endogenous NK cells to
endometriotic lesions. It seems to be a very promising
result, and if confirmed that A-NK cells are efficient in
killing endometriosis lesions, maybe in the future we
could use this approach as an alternative treatment for
women with endometriosis. Therefore, we believe it is ne-
cessary understand better decreasing of cytotoxicity of NK
cells in peritoneal fluid of women with endometriosis and
why endogenous NK cells seems not to be able to attack
endometriosis and also if exogenous A-NK cells despite
infiltrate the lesions, are really able to kill endometriosis.
Methods
The study was performed at University of Pittsburgh
Cancer Institute and approved by University ethics com-
mittee under the Protocol No 12091050.
Splenocytes from C57BL/6 B6. PL- Thy 1.1 female mice
were used for production of A-NK cells. As uterine horn
donors we used C57/BL6 +GFP female mice (transgenic
for green fluorescent protein) (Fig. 2) and endometriosis
was established in C57BL/6 (Thy1.2) female mice. All
mice were 8-12 weeks of age.
Endometriosis was induced by i.p. injection of endo-
metrial tissue fragments, according Wieser et al [13].
To stimulate proliferation of endometrial tissue, GFP
donor mice received estradiol valerate subcutaneously
(100 μg/kg dissolved in corn oil) one week before harvest
of uterine tissue. Following harvest, uterine horns were
opened and placed in a sterile Petri dish with PBS [15].
Fig. 4 Exogenous A-NK cells injected intraperitoneally localize at sites of endometriosis lesions. Fresh frozen endometriosis tissue was sectioned
and stained with PE anti-CD90.1 to reveal the i.p. injected, Thy1.1+ A-NK cells in the Thy1.2+ recipients. Sections were stained with Hoechst 33342
to reveal cell nuclei. Image resolution 20X. All micrographs (a-d) show endometriosis lesions from different animals
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The endometrium was detached from the uterine muscle
and finely chopped with a scalpel [16, 17]. Finally, the
endometrial fragments were suspended in 0.6 ml PBS and
injected i.p into recipient mice using an 18 gauge dispos-
able needle [13]. Each recipient mouse received an equal
quantity of tissue (~40 mg). Recipient mice also received
100 μg/kg estradiol valerate subcutaneously once a week,
starting one week before receiving the endometrial tissue.
This procedure was performed in order to synchronize
their estrous cycles. After 4 weeks, GFP-positive endomet-
riosis lesions were established (Fig. 1) and the experimen-
tal protocol was started [18].
Fig. 5 IL-2 treatment augments infiltration of endometriosis lesions by endogenous NK cells. Fresh frozen endometriosis tissue from animals
receiving Peg-IL-2 only was sectioned and stained with anti-NKp46 (or isotype control) followed by Alexa 488-conjugated donkey anti-goat
antibody to identify endogenous NK cells Sections were also stained with Hoechst 33342 to reveal cell nuclei. Image resolution 20X. (a-b) Isotype
control plus Alexa 488 donkey anti-goat. (c-d) Staining with anti-NKp46 plus Alexa 488 donkey anti-goat antibody reveals a substantial infiltration
of the lesions by endogenous NK cells. Image resolution 20X
Fig. 6 Infiltration of endometriosis lesions by endogenous NK and exogenous A-NK cells. Sections from endometriosis lesions were double-
stained with PE anti-Thy1.1 antibody and anti-NKp46 antibody followed by Alexa 488-conjugated donkey anti-goat antibody to identify adoptively
transferred A-NK cells (Thy1.1+/ NKp46+) and endogenous NK cells (Thy1.1-/NKp46+). Slides were stained with Hoechst 33342 (for nuclei). Image
resolution 20X. (a) Endometriosis lesion from animal that received exogenous A-NK cells i.p. (b) Endometriosis lesion from animal that received
exogenous A-NK cells by the i.v. route
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Experimental protocols
Animals were divided in 3 experimental groups with 10
animals each. Group 1 received i.v doses of 5 × 106 A-NK
in 200 μl RPMI; Group 2 received i.p dose of 5 × 106 A-
NK in 200 μl RPMI; Group 3 received i.p dose of IL2
(0.5 mL RPMI containing 30.000 IU/mL of pegylated
(PEG-) rhIL2). To support the transferred A-NK cells,
animals from group 1 and 2 received i.p. injections of
0.5 mL RPMI containing 30.000 IU/mL of pegylated
(PEG-) rhIL2 at 12 hour intervals for 3 days. Group 3
received the same amount of Peg-IL-2 (IL-2 control),
whereas control group received injections of 0.5 ml
RPMI without IL-2 [14].
A-NK cells preparation
Spleens were removed aseptically from C57BL/6 B6. PL-
Thy 1.1 female mice and a single-cell suspension was
prepared in RPMI1640. Erythrocytes were lysed by incu-
bation with ammonium chloride-potassium buffer at
room temperature for 3 min and the spleen cells were
subsequently washed twice in RPMI1640. Cells were
transferred to T150 plastic flasks (Falcon, B&D, Franklin
Lakes, NJ, USA) and cultured at 37 °C in an atmosphere
of 5 % CO2 in 50 ml of RPMI1640 supplemented with
5 % heat inactivated fetal calf serum and 5 % normal hu-
man serum, 10 ml/l non-essential amino acids (Life
Technologies), 50 mM 2-mercaptoethanol, 2 mM glu-
tamine, 20 mM Hepes buffer, 0.8 g/l streptomycin and
1.6x105u/l penicillin, hereafter referred to as complete
medium (CM). Cells were stimulated with 6.000U/mL of
human recombinant IL-2. After 3 days of incubation,
CD8-positive cells were magnetically removed following
incubation of the cell culture with rat anti-CD8 antibody
(ATCC, TIB-105) and subsequently with anti-rat coated
magnetic beads (Dynal Biotech, Lake Success, NY, USA).
The CD8-depleted cells were resuspended in fresh CM
containing 6000 IU/mL IL-2 to a final concentration of
1x105cells/ml and returned to culture flasks. After an
additional 3 days of culture, non-adherent cells were
decanted and the plastic-adherent cells were harvested
after a brief treatment with 0.02 % EDTA and washed
twice in RPMI1640 before use [11]. Routinely, these A-
NK cells were 95 % Thy1.1, 95 % asGM1, 90 % NK1.1,
2 % CD8 and 2 % CD4 [11, 14].
Adoptive transference of A-NK cells
A-NK cells were adjusted to appropriate concentrations
and injected into C57BL/6 Thy1.2 mice via lateral tail vein
(i.v.) or into the peritoneal cavity (i.p.). To support the
transferred A-NK cells, animals from group 1 and 2
received i.p. injections of 0.5 mL RPMI containing
30.000 IU/mL of pegylated (PEG-) rhIL2 at 12 hour inter-
vals for 3 days. Group 3 received the same amount of
Peg-IL-2 (IL-2 control), whereas group 4 received injections
of 0.5 ml RPMI without IL-2.
Accumulation of exogenous and endogenous NK cells in
endometriosis lesions
At three days after injection of A-NK cells, animals were
sacrificed and the lesions removed. The collected tissues
were sectioned and fixed in ice-cold acetone for 5 minutes.
Sections were stained with PE anti-rat CD90.1 to reveal the
Thy1.1+, adoptively transferred A-NK cells in the Thy1.2+
recipients. Sections we also stained with anti-NKp46 anti-
body followed by Alexa 488 donkey anti-goat antibody to
reveal endogenous NK cells (NKp46+/Thy1.1-). Before
Fig. 7 Density of endogenous and exogenous NK cells at sites of endometriosis. Endometriosis tissue was cut and stained as described in the
legend to Fig. 6. (a) Endometriosis lesion from control animal (no treatment) (b) Endometriosis lesion from animal that received PEG-IL2 only. (c)
Endometriosis lesion from animal that received i.v. A-NK cells by the i.v. route. (d) Endometriosis lesion from animals that received i.p. injection of
A-NK cells. Image resolution 20X. Slides were stained with Hoechst 33342 (for nuclei). (e) Exogenous and endogenous NK cells were identified as
PE-positive and Alexa 488-positive, PE-negative cells, respectively, and counted. Results are presented as mean number of cells/field of vision ±
SD. Endogenous NK cells (black columns), exogenous A-NK cells (gray columns)
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coverslipping, sections we stained with Hoechst 33342 to
reveal all nuclei.
The density of immune-stained cells were determined
by image analysis (MetaMorph ®) [14].
Statistical analysis
To compare all study groups, analysis of variance (ANOVA)
was performed.
Abbreviations
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Natural Killer Cells.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MLM, PHB and RAF conceived the idea; MLM and PHB did the literature
survey; MLM run the experiments and writes the manuscript; all authors
analyze the data, read and approve the final manuscript.
Acknowledgments
The authors wish to thank MSc Lisa Bailey for her valorous help during the
experiments and to Fundação de Amparo a Pesquisa do Estado de São
Paulo- FAPESP for funding the research.
This project used the UPCI Cell and Tissue Imaging Facility (CTIF), a shared
resource that is supported in part by award P30CA047904 from the NIH.
Author details
1Department of Gynecology and Obstetrics of Faculty of Medicine of
Ribeirão Preto, University of São Paulo, Ribeirao Preto, SP, Brazil. 2Department
of Immunology of University of Pittsburgh, Pittsburgh, PA, USA.
Received: 20 January 2015 Accepted: 26 June 2015
References
1. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–99.
2. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D,
D’Hooghe T. High prevalence of endometriosis in infertile women with
normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.
3. Braun DP, Ding J, Shen J, Rana N, Fernandez BB, Dmowski WP. Relationship
between apoptosis and the number of macrophages in eutopic
endometrium from women with and without endometriosis. Fertil Steril.
2002;78(4):830–5.
4. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, et al. Matrix
metalloproteinase-2, membranous type 1 matrix metalloproteinase, and
tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic
endometrium. Fertil Steril. 2002;78(4):787–95.
5. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil
Steril. 2001;75(1):1–10.
6. Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod
Immunol. 2003;50(1):48–59.
7. Manolova NDZ, Stamenova M. Immunobyology of Endometriosis. Acta
Мedica Bulgarica. 2011;38(01):38–50.
8. Basse PH, Whiteside TL, Herberman RB. Cancer immunotherapy with
interleukin-2-activated natural killer cells. Mol Biotechnol. 2002;21(2):161–70.
9. Yang Q, Goding SR, Hokland ME, Basse PH. Antitumor activity of NK cells.
Immunol Res. 2006;36(1–3):13–25.
10. Schwarz RE, Vujanovic NL, Hiserodt JC. Enhanced antimetastatic activity of
lymphokine-activated killer cells purified and expanded by their adherence
to plastic. Cancer Res. 1989;49(6):1441–6.
11. Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC, et al.
Tumor-localization by adoptively transferred, interleukin-2-activated NK cells
leads to destruction of well-established lung metastases. Int J Cancer.
2003;105(4):512–9.
12. Velasco I, Quereda F, Bermejo R, Campos A, Acien P. Intraperitoneal
recombinant interleukin-2 activates leukocytes in rat endometriosis.
J Reprod Immunol. 2007;74(1–2):124–32.
13. Wieser F, Wu J, Shen Z, Taylor RN, Sidell N. Retinoic acid suppresses growth
of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage
differentiation in an immunocompetent mouse model of endometriosis.
Fertil Steril. 2012;97(6):1430–7.
14. Goding S, Yang Q, Mi Z, Robbins PD, Basse PH. Targeting of products of
genes to tumor sites using adoptively transferred A-NK and T-LAK cells.
Cancer Gene Ther. 2007;14(5):441–50.
15. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, et al.
Macrophages are alternatively activated in patients with endometriosis and
required for growth and vascularization of lesions in a mouse model of
disease. Am J Pathol. 2009;175(2):547–56.
16. Burns KA, Rodriguez KF, Hewitt SC, Janardhan KS, Young SL, Korach KS.
Role of estrogen receptor signaling required for endometriosis-like lesion
establishment in a mouse model. Endocrinology. 2012;153(8):3960–71.
17. Mariani M, Vigano P, Gentilini D, Camisa B, Caporizzo E, Di Lucia P, et al.
The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis
development in a mouse model by inhibiting peritoneal inflammation.
Hum Reprod. 2012;27(7):2010–9.
18. Revised American Society for Reproductive Medicine classification of
endometriosis: 1996. Fertil Steril. 1997, 67(5):817–21.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Montenegro et al. BMC Immunology  (2015) 16:51 Page 7 of 7
